Role of antimicrobial photodynamic therapy in reducing whole salivary oral yeasts colonization in type-2 diabetic and non-diabetic patients with and without dental implants

被引:5
|
作者
Labban, Nawaf [1 ]
Alfouzan, Afnan F. [1 ]
Al Taweel, Sara Mohammad [1 ]
ALRabiah, Mohammed A. [1 ]
Assery, Mansour K. [2 ]
机构
[1] King Saud Univ, Coll Dent, Dept Prosthet Dent Sci, POB 60169, Riyadh 11545, Saudi Arabia
[2] Riyadh Elm Univ, Dept Prosthodont, Riyadh, Saudi Arabia
关键词
Antimicrobial photodynamic therapy; Candida; Type-2 diabetes mellitus; Oral yeasts; Unstimulated whole saliva; CANDIDA-ALBICANS; SPECIES PREVALENCE; CHRONIC PERIODONTITIS; GUTKA-CHEWERS; CARRIAGE; MELLITUS; CIGARETTE; BIOFILMS; SMOKERS;
D O I
10.1016/j.pdpdt.2021.102183
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim was to assess the impact of antimicrobial photodynamic therapy (aPDT) in reducing whole salivary oral yeasts colonization in type-2 diabetic and non-diabetic patients with dental implants. Methods: Type-2 diabetic and self-reported non-diabetic patients were included. Participants were divided into the following groups: Group-1: Type-2 diabetic patients with dental implants; Group-2: Non-diabetic patients with dental implants; Group-3: Type-2 diabetic patients without dental prostheses; Group-4: Non-diabetic pa-tients without dental prostheses. In each group, participants were subdivided into 2-sub-groups. In the test-subgroup, participants received routine oral hygiene maintenance instructions (OHMI) and underwent full mouth disinfection using aPDT; and in the control-group, participants received OHMI alone. Unstimulated whole saliva samples were collected, hemoglobin A1c levels were measured and yeast colonization was assessed at baseline and at 3-months' follow-up in all groups. Sample-size estimation was done and group-comparisons were done. P-values <0.01 were considered statistically significant. Results: At baseline, the mean oral yeasts colonization was significantly higher among patients in Group-1 (P < 0.001) and 3 (P < 0.001) compared with individuals in groups 2 (P < 0.001) and 4 (P < 0.001). At baseline and at 3-months of follow-up, the mean HbA1c levels and oral yeasts colonization were significantly higher among patients in Group-1 (P < 0.001) and 3 (P < 0.001) compared with individuals in groups 2 (P < 0.001) and 4 (P < 0.001). Conclusion: In the short-term, routine OHMI with adjunct aPDT is more effective in reducing whole salivary oral yeasts counts than OHMI alone in patients with and without dental implants.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study
    Kardalas, Efstratios
    Paikopoulou, Aggeliki
    Vassiliadi, Dimitra A.
    Kounatidis, Dimitris
    Vallianou, Natalia G.
    Vourlakou, Christine
    Karampela, Irene
    Dalamaga, Maria
    Tzanela, Marinella
    Stratigou, Theodora
    METABOLISM OPEN, 2024, 23
  • [42] Clinical and Radiographic Peri-Implant Parameters and Whole Salivary Interleukin-1β and Interleukin-6 Levels among Type-2 Diabetic and Nondiabetic Patients with and without Peri-Implantitis
    Al-Askar, Mansour
    Ajlan, Sumaiah
    Alomar, Nuha
    Al-Daghri, Nasser M.
    MEDICAL PRINCIPLES AND PRACTICE, 2018, 27 (02) : 133 - 138
  • [43] Demonstration of advanced glycation end product (AGE) expression in bladder cancer tissue in type-2 diabetic and non-diabetic patients and the relationship between AGE accumulation and endoplasmic reticulum stress with bladder cancer
    Karkin, Kadir
    Izol, Volkan
    Kaplan, Mahir
    Deger, Mutlu
    Akdogan, Nebil
    Tansug, Mustafa Zuhtu
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021,
  • [44] Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin
    Quinzler, Renate
    Ude, Miriam
    Franzmann, Alexandra
    Feldt, Sandra
    Schuessell, Katrin
    Leuner, Kristina
    Mueller, Walter E.
    Dippel, Franz-Werner
    Schulz, Martin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (01) : 24 - 32
  • [45] A CROSS-SECTIONAL SURVEY ON ECONOMIC BURDEN OF TYPE-2 DIABETES MELLITUS PATIENTS WITH ORAL ANTI-DIABETIC DRUGS THERAPY IN CHINA
    Ji, L.
    Ye, Q.
    Chang, J. H.
    Liu, G. G.
    VALUE IN HEALTH, 2011, 14 (03) : A96 - A96
  • [46] CHOLESTEROL-BIOSYNTHESIS IN NONKETOTIC TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS BEFORE AND DURING INSULIN THERAPY
    ANDERSEN, E
    HELLSTROM, K
    DIABETOLOGIA, 1986, 29 (08) : A513 - A513
  • [47] EFFECTS OF THE COMBINATION OF INSULIN AND GLIBENCLAMIDE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH SECONDARY FAILURE TO ORAL HYPOGLYCEMIC AGENTS
    STENMAN, S
    GROOP, PH
    SALORANTA, C
    TOTTERMAN, KJ
    FYHRQVIST, F
    GROOP, L
    DIABETOLOGIA, 1988, 31 (04) : 206 - 213
  • [48] PLASMA ISLET AMYLOID POLYPEPTIDE (AMYLIN) LEVELS AND THEIR RESPONSES TO ORAL GLUCOSE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    SANKE, T
    HANABUSA, T
    NAKANO, Y
    OKI, C
    OKAI, K
    NISHIMURA, S
    KONDO, M
    NANJO, K
    DIABETOLOGIA, 1991, 34 (02) : 129 - 132
  • [49] THE ROLE OF C-PEPTIDE IN THE CHOICE OF TREATMENT FOR POORLY CONTROLLED TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    RAVNIKOBLAK, M
    DIABETOLOGIA, 1987, 30 (07) : A573 - A573
  • [50] RENAL EFFECTS OF NICARDIPINE, A CALCIUM-ANTAGONIST, IN HYPERTENSIVE TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT NEPHROPATHY
    BABA, T
    TOMIYAMA, T
    MURABAYASHI, S
    TAKEBE, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (05) : 425 - 429